Interim phase-3 trial results show Sputnik V vaccine has 91.6% efficacy
The efficacy was 91.6% after the first dose. Although the study was not designed to assess the efficacy of a
Read More
Day: February 2, 2021
The efficacy was 91.6% after the first dose. Although the study was not designed to assess the efficacy of a
Read More